Pharmacogenetics of sulfotransferase

Citation
K. Nagata et Y. Yamazoe, Pharmacogenetics of sulfotransferase, ANN R PHARM, 40, 2000, pp. 159-176
Citations number
94
Categorie Soggetti
Pharmacology & Toxicology
Journal title
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
ISSN journal
03621642 → ACNP
Volume
40
Year of publication
2000
Pages
159 - 176
Database
ISI
SICI code
0362-1642(2000)40:<159:POS>2.0.ZU;2-7
Abstract
Cytosolic sulfotransferase catalyzes sulfoconjugation of relatively small l ipophilic endobiotics and xenobiotics. At least 44 cytosolic sulfotransfera ses have been identified from mammals, and based on their amino acid sequen ces, these forms are shown to constitute five different families. In humans , 10 sulfotransferase genes have been identified and shown to localize on a t least five different chromosomes. The enzymatic properties characterized in the recombinant forms indicate the association of their substrate specif icity with metabolisms of such nonpeptide hormones as estrogen, corticoid, and thyroxine, although most forms are also active on the sulfation of vari ous xenobiotics. Genetic polymorphisms are observed on such human sulfotran sferases as ST1A2, ST1A3, and ST2A3.